Lexicon Pharmaceuticals, Inc.
(NASDAQ : LXRX)

( )
LXRX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Loading LXRX News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.32%73.350.9%$628.11m
CELGCelgene Corporation
-0.08%131.261.1%$437.57m
AMGNAmgen Inc.
0.79%171.391.1%$428.25m
VRTXVertex Pharmaceuticals Incorporated
-0.88%151.371.9%$388.67m
BIIBBiogen Inc.
2.14%294.081.2%$369.29m
REGNRegeneron Pharmaceuticals, Inc.
-0.85%468.542.7%$323.23m
ALXNAlexion Pharmaceuticals, Inc.
0.99%136.551.9%$224.00m
ILMNIllumina, Inc.
0.12%194.153.5%$222.63m
SRPTSarepta Therapeutics, Inc.
1.96%37.4319.8%$145.52m
INCYIncyte Corporation
-1.61%124.342.6%$135.50m
CLVSClovis Oncology, Inc.
-0.15%71.7718.0%$123.60m
KITEKite Pharma, Inc.
1.02%128.0916.1%$116.66m
TSROTESARO, Inc.
-0.89%112.9914.7%$114.54m
BMRNBioMarin Pharmaceutical Inc.
-0.01%83.074.4%$113.75m
AAgilent Technologies, Inc.
4.67%62.151.5%$112.87m

Company Profile

Lexicon Pharmaceuticals, Inc. operates as a biopharmaceutical company which focuses on the development of breakthrough treatments for human disease. It has multiple programs in clinical development for diabetes, irritable bowel syndrome, carcinoid syndrome and other indications. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.